Stockholders’ Equity (Deficit) (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2024 |
Dec. 31, 2023 |
| Defined Benefit Plan Disclosure [Line Items] |
|
|
| Schedule of Company Nonvested Shares |
A
summary of the Company’s nonvested shares (due to service based restrictions) as of June 30, 2024 and December 31, 2023, is presented
below:
Schedule
of Company Nonvested Shares
| | |
| | |
Weighted Average | |
| | |
Number of | | |
Gant Date | |
| Non-Vested Shares | |
Shares | | |
Fair Value | |
| Balance - December 31, 2022 | |
| 42,192 | | |
$ | 1.40 | |
| Granted | |
| 330,554 | | |
| 5.77 | |
| Vested | |
| (104,699 | ) | |
| 6.72 | |
| Cancelled/Forfeited | |
| (153,711 | ) | |
| 5.53 | |
| Balance - December 31, 2023 | |
| 114,336 | | |
| 6.40 | |
| Granted | |
| - | | |
| - | |
| Vested | |
| (88,336 | ) | |
| 5.15 | |
| Cancelled/Forfeited | |
| - | | |
| - | |
| Balance - June 30, 2024 | |
| 26,000 | | |
$ | 6.40 | |
|
A
summary of the Company’s nonvested shares (due to service based restrictions) as of December 31, 2023 and 2022, is presented below:
Schedule of Company Nonvested Shares
| Non-Vested
Shares | |
Number
of Shares | | |
Weighted
Average Gant Date Fair Value | |
| Balance
- December 31, 2021 | |
| 15,878 | | |
$ | 8.18 | |
| Granted | |
| 48,340 | | |
| 12.60 | |
| Vested | |
| (20,277 | ) | |
| 53.80 | |
| Cancelled/Forfeited | |
| (1,750 | ) | |
| 40.00 | |
| Balance
- December 31, 2022 | |
| 42,191 | | |
| 1.40 | |
| Granted | |
| 330,554 | | |
| 5.77 | |
| Vested | |
| (104,698 | ) | |
| 6.72 | |
| Cancelled/Forfeited | |
| (153,711 | ) | |
| 5.53 | |
| Balance
- December 31, 2023 | |
| 114,336 | | |
$ | 5.43 | |
|
| Schedule of Stock Option Activity |
Stock
option transactions for the year ended December 31, 2023 is summarized as follows:
Schedule
of Stock Option Activity
| | |
| | |
| | |
Weighted | | |
| | |
Weighted | |
| | |
| | |
Weighted | | |
Average | | |
| | |
Average | |
| | |
| | |
Average | | |
Remaining | | |
Aggregate | | |
Grant | |
| | |
Number of | | |
Exercise | | |
Contractual | | |
Intrinsic | | |
Date | |
| Stock Options | |
Options | | |
Price | | |
Term (Years) | | |
Value | | |
Fair Value | |
| Outstanding - December 31, 2022 | |
| 37,392 | | |
$ | 19.05 | | |
| 3.68 | | |
$ | - | | |
$ | - | |
| Vested and Exercisable - December 31, 2022 | |
| 34,526 | | |
$ | 19.44 | | |
| 3.47 | | |
$ | - | | |
$ | - | |
| Unvested and non-exercisable - December 31, 2022 | |
| 2,866 | | |
$ | 14.36 | | |
| 4.16 | | |
$ | - | | |
$ | - | |
| Granted | |
| 101,930 | | |
$ | 17.41 | | |
| | | |
| | | |
$ | 0.73 | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| (139,322 | ) | |
$ | 17.85 | | |
| | | |
| | | |
| | |
| Outstanding - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
| Vested and Exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
| Unvested and non-exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
|
Stock
option transactions for the years ended December 31, 2023 and 2022 are summarized as follows:
Schedule
of Stock Option Activity
| Stock
Options | |
Number
of Options | | |
Weighted
Average Exercise Price | | |
Weighted
Average Remaining Contractual Term (Years) | | |
Aggregate
Intrinsic Value | | |
Weighted
Average Grant Date Fair Value | |
| Outstanding
- December 31, 2021 | |
| 8,769 | | |
$ | 35.60 | | |
| 3.25 | | |
$ | - | | |
$ | - | |
| Vested
and Exercisable - December 31, 2021 | |
| 8,769 | | |
$ | 35.60 | | |
| 3.25 | | |
$ | - | | |
$ | - | |
| Unvested
and non-exercisable - December 31, 2021 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
| Granted | |
| 28,623 | | |
$ | 13.97 | | |
| | | |
| | | |
$ | 12.49 | |
| Exercised | |
| - | | |
| - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| - | | |
| | | |
| | | |
| | |
| Outstanding
- December 31, 2022 | |
| 37,392 | | |
$ | 19.05 | | |
| 3.68 | | |
$ | - | | |
$ | - | |
| Vested
and Exercisable - December 31, 2022 | |
| 34,526 | | |
$ | 19.44 | | |
| 3.47 | | |
$ | - | | |
$ | - | |
| Unvested
and non-exercisable - December 31, 2022 | |
| 2,866 | | |
$ | 14.36 | | |
| 4.16 | | |
$ | - | | |
$ | - | |
| Granted | |
| 101,930 | | |
$ | 17.41 | | |
| | | |
| | | |
$ | 0.73 | |
| Exercised | |
| - | | |
$ | - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| (139,322 | ) | |
$ | 17.85 | | |
| | | |
| | | |
| | |
| Outstanding
- December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
| Vested
and Exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
| Unvested
and non-exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | | |
$ | - | |
|
| Schedule of Fair Value Assumptions |
The
fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:
Schedule
of Fair Value Assumptions
| Expected term (years) | |
| 5.00 | |
| Expected volatility | |
| 59%
- 62 | % |
| Expected dividends | |
| 0 | % |
| Risk free interest rate | |
| 4.00 | % |
|
The
fair value of the stock options granted in 2023 were determined using the Black-Scholes Option pricing model with the following assumptions:
Schedule of Fair Value Assumptions
| Expected
term (years) | |
| 5.00 | |
| Expected
volatility | |
| 59%
- 62% | |
| Expected
dividends | |
| 0 | % |
| Risk
free interest rate | |
| 4.00 | % |
| Expected
term (years) | |
| 5.00 | |
| Expected
volatility | |
| 62 | % |
| Expected
dividends | |
| 0 | % |
| Risk
free interest rate | |
| 1.64 | % |
|
| Schedule of Stock Warrant Activity |
Warrant
activity for the six months ended June 30, 2024 and the year ended December 31, 2023 are summarized as follows:
Schedule
of Stock Warrant Activity
| | |
| | |
| | |
Weighted | | |
| |
| | |
| | |
| | |
Average | | |
| |
| | |
| | |
Weighted | | |
Remaining | | |
Aggregate | |
| | |
Number of | | |
Average | | |
Contractual | | |
Intrinsic | |
| Warrants | |
Warrants | | |
Exercise Price | | |
Term (Years) | | |
Value | |
| Outstanding - December 31, 2022 | |
| 81,452 | | |
$ | 10.36 | | |
| 2.22 | | |
$ | 82,756 | |
| Vested and Exercisable - December 31, 2022 | |
| 81,452 | | |
$ | 10.36 | | |
| 2.22 | | |
$ | 82,756 | |
| Unvested - December 31, 2022 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Granted | |
| - | | |
| | | |
| | | |
| | |
| Exercised | |
| - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| | | |
| | | |
| | |
| Outstanding - December 31, 2023 | |
| 81,452 | | |
$ | 10.36 | | |
| 1.22 | | |
$ | 36,030 | |
| Vested and Exercisable - December 31, 2023 | |
| 81,452 | | |
$ | 10.36 | | |
| 1.22 | | |
$ | 36,030 | |
| Unvested and non-exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Granted | |
| - | | |
| | | |
| | | |
| | |
| Exercised | |
| - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| | | |
| | | |
| | |
| Outstanding - June 30, 2024 | |
| 81,452 | | |
$ | 10.36 | | |
| 0.73 | | |
$ | 3,199 | |
| Vested and Exercisable - June 30, 2024 | |
| 81,452 | | |
$ | 10.36 | | |
| 0.73 | | |
$ | 3,199 | |
| Unvested and non-exercisable - June 30, 2024 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
|
Warrant
activity for the years ended December 31, 2023 and 2022 are summarized as follows:
Schedule
of Stock Warrant Activity
| Warrants | |
Number
of Warrants | | |
Weighted
Average Exercise Price | | |
Weighted
Average Remaining Contractual Term (Years) | | |
Aggregate
Intrinsic
Value | |
| Outstanding
- December 31, 2021 | |
| 81,452 | | |
$ | 10.36 | | |
| 3.22 | | |
$ | - | |
| Vested
and Exercisable - December 31, 2021 | |
| 81,452 | | |
$ | 10.36 | | |
| 3.22 | | |
$ | - | |
| Unvested
- December 31, 2021 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Granted | |
| - | | |
| | | |
| | | |
| | |
| Exercised | |
| - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| | | |
| | | |
| | |
| Outstanding
- December 31, 2022 | |
| 81,452 | | |
$ | 10.36 | | |
| 2.22 | | |
$ | 82,756 | |
| Vested
and Exercisable - December 31, 2022 | |
| 81,452 | | |
$ | 10.36 | | |
| 2.22 | | |
$ | 82,756 | |
| Unvested
- December 31, 2022 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
| Granted | |
| - | | |
| | | |
| | | |
| | |
| Exercised | |
| - | | |
| | | |
| | | |
| | |
| Cancelled/Forfeited | |
| - | | |
| | | |
| | | |
| | |
| Outstanding
- December 31, 2023 | |
| 81,452 | | |
$ | 10.36 | | |
| 1.22 | | |
$ | 36,030 | |
| Vested
and Exercisable - December 31, 2023 | |
| 81,452 | | |
$ | 10.36 | | |
| 1.22 | | |
$ | 36,030 | |
| Unvested
and non-exercisable - December 31, 2023 | |
| - | | |
$ | - | | |
| - | | |
$ | - | |
|
| Related Party [Member] |
|
|
| Defined Benefit Plan Disclosure [Line Items] |
|
|
| Schedule of Classes of stock |
The
following represents the Company’s three (3) classes of stock:
Schedule
of Classes of stock
| June
30, 2024 |
| | |
Shares
Authorized | | |
Issued | | |
Outstanding | | |
Designated | | |
Par
Value | | |
Votes
Per Share | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Preferred
Stock | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Preferred
Stock | |
| 50,000,000 | | |
| | | |
| | | |
| | | |
$ | 0.00001 | | |
| | |
| Series
X | |
| | | |
| 1 | | |
| 1 | | |
| 1 | | |
$ | 0.00001 | | |
| A | |
| | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Common
Stock | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Series
A | |
| 500,000,000 | | |
| 17,700,000 | | |
| 15,000,000 | | |
| | | |
$ | 0.00001 | | |
| 1 | |
| Series
B | |
| 500,000,000 | | |
| 11,800,000 | | |
| 10,000,000 | | |
| | | |
$ | 0.00001 | | |
| 10 | |
| | |
| 1,000,000,000 | | |
| 29,500,000 | | |
| 25,000,000 | | |
| - | | |
| | | |
| | |
A
- Series X will have a number of votes at any time equal to all of the number of votes held by all other voting equity securities, plus
one share. Currently, the Series X preferred stockholder controls the Company through their super voting rights.
| December
31, 2023 |
| | |
Shares
Authorized | | |
Issued | | |
Outstanding | | |
Designated | | |
Par
Value | | |
Votes
Per Share | |
| | |
| | |
| | |
| | |
| | |
| | |
| |
| Common
Stock | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| Series
A | |
| 500,000,000 | | |
| 17,700,000 | | |
| 15,000,000 | | |
| | | |
$ | 0.00001 | | |
| 1 | |
| Series
B | |
| 500,000,000 | | |
| 11,800,000 | | |
| 10,000,000 | | |
| | | |
$ | 0.00001 | | |
| 10 | |
| | |
| 1,000,000,000 | | |
| 29,500,000 | | |
| 25,000,000 | | |
| - | | |
| | | |
| | |
|
|
| Schedule of Company Nonvested Series A and B of Common Stock |
The
following is a summary of the Company’s non-vested Series A and B shares of common stock at June 30, 2024 and December 31, 2023,
respectively:
Schedule
of Company Nonvested Series A and B of Common Stock
| | |
| | |
Weighted
Average | |
| Non-Vested
Shares | |
Number
of Shares | | |
Grant
Date Fair Value | |
| Balance
- December 31, 2023 | |
| - | | |
$ | - | |
| Granted | |
| 4,500,000 | | |
| 2.03 | |
| Vested | |
| - | | |
| - | |
| Cancelled/Forfeited | |
| - | | |
| - | |
| Balance
- June 30, 2024 | |
| 4,500,000 | | |
$ | 2.03 | |
| | |
| | | |
| | |
| Unrecognized
Compensation | |
$ | 8,373,750 | | |
| | |
| | |
| | | |
| | |
| Weighted
average remaining period (years) | |
| 3.67 | | |
| | |
|
|